{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:19:10Z","timestamp":1780449550153,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Intramural Research Grant","award":["2-5, 29-4"],"award-info":[{"award-number":["2-5, 29-4"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lately, monoclonal gammopathy of renal significance (MGRS) has been defined as a group of renal disorders that are strongly associated with monoclonal protein, including amyloid immunoglobulin light chain (AL) amyloidosis. Amyloid myopathy is rare (1.5% of all patients with amyloidosis) and the prognosis is poor. Furthermore, only approximately 20% of patients with amyloid myopathy are reported to have renal involvement, indicating a lack of data in the literature.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here, we report a rare case of MGRS-related AL amyloidosis complicated by amyloid myopathy that presented with muscle weakness in the upper and lower limbs, neck and fingers, and nephrotic syndrome. Blood, urine, and bone marrow examination revealed monoclonal gammopathy of undetermined significance (MGUS) (Bence Jones protein-lambda). Muscle biopsy of the vastus lateralis muscle demonstrated amyloid proteins in the sarcolemma and in the blood vessel walls on Congo red staining, suggesting amyloid myopathy, and tiny inclusions in fibers on modified Gomori trichrome stain. Although we thought they were reminiscent of nemaline bodies, we could not confirm the nature of this structure. Renal biopsy demonstrated amyloid proteins in the mesangial region, part of the capillary walls, and the blood vessel walls on direct fast scarlet staining. As these amyloid proteins were positive for p-component staining and negative for amyloid A staining, \u03b22-microglobulin, and pre-albumin, and as lambda light chains were positive in the mesangial region, we diagnosed the patient with MGRS-related AL amyloidosis. Although he was treated with melphalan and dexamethasone, his symptoms did not improve.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>AL amyloidosis involving the kidneys and muscles has a poor prognosis, and a delayed diagnosis of amyloid myopathy is common because of its rarity and frequent misdiagnosis, which increases organ function deterioration. Therefore, early detection, therapeutic intervention, and careful follow-up are crucial.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-021-02272-7","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T18:24:39Z","timestamp":1614450279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Monoclonal gammopathy of renal significance (MGRS)-related AL amyloidosis complicated by amyloid myopathy: a case report"],"prefix":"10.1186","volume":"22","author":[{"given":"Erina","family":"Ono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Koita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ayaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Tanigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Takayanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichiro","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Minamiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Yanagita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,27]]},"reference":[{"key":"2272_CR1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ki.2014.408","volume":"87","author":"F Bridoux","year":"2015","unstructured":"Bridoux F, Leung N, Hutchison CA, Touchard G, Sethi S, Fermand JP, et al. Diagnosis of monoclonal gammopathy of renal significance. Kidney Int. 2015;87:698\u2013711.","journal-title":"Kidney Int"},{"key":"2272_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","volume":"15","author":"N Leung","year":"2019","unstructured":"Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D\u2019Agati VD, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the international kidney and monoclonal Gammopathy research group. Nat Rev Nephrol. 2019;15:45\u201359.","journal-title":"Nat Rev Nephrol"},{"key":"2272_CR3","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.2215\/CJN.02920316","volume":"11","author":"MH Rosner","year":"2016","unstructured":"Rosner MH, Edeani A, Yanagita M, Glezerman IG, Leung N, American Society of Nephrology Onco-Nephrology Forum. Paraprotein-related kidney disease: diagnosing and treating monoclonal gammopathy of renal significance. Clin J Am Soc Nephrol. 2016;11:2280\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2272_CR4","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","volume":"120","author":"N Leung","year":"2012","unstructured":"Leung N, Bridoux F, Hutchison CA, Nasr SH, Cockwell P, Fermand JP, et al. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood. 2012;120:4292\u20135.","journal-title":"Blood."},{"key":"2272_CR5","doi-asserted-by":"publisher","first-page":"e2018022","DOI":"10.4084\/mjhid.2018.022","volume":"10","author":"P Milani","year":"2018","unstructured":"Milani P, Merlini G, Palladini G. Light chain amyloidosis. Mediterr J Hematol Infect Dis. 2018;10:e2018022.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"2272_CR6","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","volume":"30","author":"S Kumar","year":"2012","unstructured":"Kumar S, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Colby C, et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol. 2012;30:989\u201395.","journal-title":"J Clin Oncol"},{"key":"2272_CR7","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.mayocp.2016.06.027","volume":"91","author":"E Muchtar","year":"2016","unstructured":"Muchtar E, Derudas D, Mauermann M, Liewluck T, Dispenzieri A, Kumar SK, et al. Systemic immunoglobulin light chain amyloidosis-associated myopathy: presentation, diagnostic pitfalls, and outcome. Mayo Clin Proc. 2016;91:1354\u201361.","journal-title":"Mayo Clin Proc"},{"key":"2272_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/mus.20169","volume":"31","author":"JE Chapin","year":"2005","unstructured":"Chapin JE, Kornfeld M, Harris A. Amyloid myopathy: characteristic features of a still underdiagnosed disease. Muscle Nerve. 2005;31:266\u201372.","journal-title":"Muscle Nerve"},{"key":"2272_CR9","first-page":"9840405","volume":"2018","author":"F Accardi","year":"2018","unstructured":"Accardi F, Papa V, Capozzi AR, Capello GL, Verga L, Mancini C, et al. A rare case of systemic AL amyloidosis with muscle involvement: a misleading diagnosis. Case Rep Hematol. 2018;2018:9840405.","journal-title":"Case Rep Hematol"},{"key":"2272_CR10","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/ene.13448","volume":"24","author":"T Liewluck","year":"2017","unstructured":"Liewluck T, Milone M. Characterization of isolated amyloid myopathy. Eur J Neurol. 2017;24:1437\u201345.","journal-title":"Eur J Neurol"},{"key":"2272_CR11","first-page":"713","volume":"41","author":"AG Engel","year":"1966","unstructured":"Engel AG. Late-onset rod myopathy (a new syndrome?): light and electron microscopic observations in two cases. Mayo Clin Proc. 1966;41:713\u201341.","journal-title":"Mayo Clin Proc"},{"key":"2272_CR12","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1212\/01.wnl.0000180362.90078.dc","volume":"65","author":"N Chahin","year":"2005","unstructured":"Chahin N, Selcen D, Engel AG. Sporadic late onset nemaline myopathy. Neurology. 2005;65:1158\u201364.","journal-title":"Neurology."},{"key":"2272_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrrheum.2010.84","volume":"6","author":"F Perfetto","year":"2010","unstructured":"Perfetto F, Moggi-Pignone A, Livi R, Tempestini A, Bergesio F, Matucci-Cerinic M. Systemic amyloidosis: a challenge for the rheumatologist. Nat Rev Rheumatol. 2010;6:417\u201329.","journal-title":"Nat Rev Rheumatol"},{"key":"2272_CR14","first-page":"949","volume":"27","author":"LA Mandl","year":"2000","unstructured":"Mandl LA, Folkerth RD, Pick MA, Weinblatt ME, Gravallese EM. Amyloid myopathy masquerading as polymyositis. J Rheumatol. 2000;27:949\u201352.","journal-title":"J Rheumatol"},{"key":"2272_CR15","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1182\/blood-2006-03-001164","volume":"108","author":"G Merlini","year":"2006","unstructured":"Merlini G, Stone MJ. Dangerous small B-cell clones. Blood. 2006;108:2520\u201330.","journal-title":"Blood."},{"key":"2272_CR16","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ana.410430606","volume":"43","author":"S Spuler","year":"1998","unstructured":"Spuler S, Emslie-Smith A, Engel AG. Amyloid myopathy: an underdiagnosed entity. Ann Neurol. 1998;43:719\u201328.","journal-title":"Ann Neurol"},{"key":"2272_CR17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mus.23287","volume":"45","author":"LW Ostrow","year":"2012","unstructured":"Ostrow LW, Corse AM, Morrison BM, Huff CA, Carrino JA, Hoke A, et al. Expanding the spectrum of monoclonal light chain deposition disease in muscle. Muscle Nerve. 2012;45:755\u201361.","journal-title":"Muscle Nerve"},{"key":"2272_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13023-017-0640-2","volume":"12","author":"LJ Schnitzler","year":"2017","unstructured":"Schnitzler LJ, Schreckenbach T, Nadaj-Pakleza A, Stenzel W, Rushing EJ, Van Damme P, et al. Sporadic late-onset nemaline myopathy: clinic-pathological characteristics and review of 76 cases. Orphanet J Rare Dis. 2017;12:86.","journal-title":"Orphanet J Rare Dis"},{"key":"2272_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/WCO.0000000000000477","volume":"30","author":"A Uruha","year":"2017","unstructured":"Uruha A, Benveniste O. Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance. Curr Opin Neurol. 2017;30:457\u201363.","journal-title":"Curr Opin Neurol"},{"key":"2272_CR20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s00415-018-8741-y","volume":"265","author":"M Monforte","year":"2018","unstructured":"Monforte M, Primiano G, Silvestri G, Mirabella M, Luigetti M, Cuccagna C, et al. Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort. J Neurol. 2018;265:542\u201351.","journal-title":"J Neurol"},{"key":"2272_CR21","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.2169\/internalmedicine.2247-18","volume":"58","author":"K Nakamura","year":"2019","unstructured":"Nakamura K, Shibuya K, Nishino I, Kuwabara S. Dropped head in sporadic late-onset nemaline myopathy. Intern Med. 2019;58:1967\u20138.","journal-title":"Intern Med"},{"key":"2272_CR22","doi-asserted-by":"crossref","unstructured":"Mizuno Y, Mori-Yoshimura M, Okamoto T, Oya Y, Nishino I, Murata M. [Two cases of sporadic late onset nemaline myopathy effectively treated with immunotherapy]. Rinsho Shinkeigaku. 2016; 56:605-11. Japanese.","DOI":"10.5692\/clinicalneurol.cn-000893"},{"key":"2272_CR23","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.nmd.2018.04.011","volume":"28","author":"T Kumutpongpanich","year":"2018","unstructured":"Kumutpongpanich T, Owattanapanich W, Tanboon J, Nishino I, Boonyapisit K. Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance (SLONM-MGUS): an alternative treatment using cyclophosphamide-thalidomide-dexamethasone (CTD) regimen. Neuromuscul Disord. 2018;28:610\u20133.","journal-title":"Neuromuscul Disord"},{"key":"2272_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41408-018-0080-9","volume":"8","author":"MA Gertz","year":"2018","unstructured":"Gertz MA. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018. Blood Cancer J. 2018;8:44.","journal-title":"Blood Cancer J"},{"key":"2272_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1471-2369-13-118","volume":"13","author":"T Kuroda","year":"2012","unstructured":"Kuroda T, Tanabe N, Kobayashi D, Wada Y, Murakami S, Nakano M, et al. Significant association between renal function and amyloid-positive area in renal biopsy specimens in AL amyloidosis. BMC Nephrol. 2012;13:118.","journal-title":"BMC Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02272-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-021-02272-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02272-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T18:25:21Z","timestamp":1614450321000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02272-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,27]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2272"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02272-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,27]]},"assertion":[{"value":"30 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This case report was written in compliance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication of this case report was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}